NHS England has confirmed that funding to support a 4% pay rise for employed practice pharmacists and other staff has been uplifted and that it ‘expects’ employers to pass on the rise for 2025/26.
In a letter on Thursday, NHS England announced that the global sum for GP practices in England has been increased from £121.79 to £123.34 per patient to allow for the pay rise recommended by the pay review body.
For 2025/26, the government committed to ‘uplifting the pay element of the GP contract’ by 4%, following the Review Body on Doctors’ and Dentists’ Remuneration (DDRB) recommendations around partners and salaried general practice staff, including pharmacists.
Now NHS England has confirmed the global sum will rise by 1.2% to cover the recommended pay rise, in addition to the 2.8% already included in contract funding at the start of 2025/26. This will be backdated to April, it confirmed.
In a letter to integrated care boards (ICBs) this week, NHS England said: ‘The GP contract has been amended to uplift the pay elements of the contract by 4%, backdated to 1 April 2025 (a further 1.2% in addition to the 2.8% already included in contract funding at the start of 2025/26).
‘The DDRB pay uplift will be implemented through an increase to the global sum, with payments backdated to 1 April 2025 in the August Primary Care Support England (PCSE) payment runs. The new global sum for 2025/26 is £123.34.’
NHS England said this increase to practice funding ‘enables the 4% pay uplift with backdated payments to be passed on to salaried and contractor GPs’ and pay uplifts for other practice staff’.
‘NHS England expects general practice contractors to implement pay rises to other practice staff in line with the uplift in funding they are receiving,’ it added.
The government has also agreed to backdate uplifts to the ARRS maximum reimbursement amounts – which also includes pharmacists – to 1 April 2025 and uplift the pay-related elements of the general practice workforce transformational (SDF) funding.
In July, the government confirmed that primary care networks (PCNs) would be given additional funding to cover a 3.6% pay uplift for ARRS pharmacists and other non-GPs employed under the scheme, in line with the 2025/26 pay recommendation for NHS Agenda for Change staff.
Last week, the health and social care secretary kickstarted the 2026/27 pay round for general practice and NHS staff by asking the independent review bodies to support an ‘earlier’ and ‘more timely’ pay announcement.
A version of this article was first published by our sister title Pulse
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.